Forbion Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
31
- Investments
-
213
- Portfolio
-
54
- Exits
-
91
Forbion General Information
Company Description
Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands. The firm seeks to invest in life sciences and bioeconomy companies operating in autoimmune & inflammation, cardiovascular & metabolic, central nervous system, digestive & renal, oncology, ophthalmology, orphan & rare disease, respiratory, food, agriculture, materials, and environmental technologies sectors across Europe & North American.
Business Details
Website
www.forbion.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Gooimeer 2-35
- 1411 DC Naarden
- Netherlands
Forbion Investments & Acquisitions (213)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Numab | 09-Jan-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Verdiva Bio | 09-Jan-2025 | Other Healthcare Services | Clinical Trials - Phase 2 | |||
| Orbis Medicines | 06-Jan-2025 | Drug Discovery | Generating Revenue | |||
| Noema Pharma | 11-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Citryll | 09-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| SynOx Therapeutics | 30-Oct-2024 | Drug Discovery | Clinical Trials - Phase 3 | |||
| enGene (Biotechnology) | 25-Oct-2024 | Biotechnology | Clinical Trials - General | |||
| Purespring Therapeutics | 08-Oct-2024 | Drug Discovery | Pre-Clinical Trials | |||
| LoQus23 Therapeutics | 02-Oct-2024 | Later Stage VC | Biotechnology | Generating Revenue | ||
| F2G | 12-Sep-2024 | Later Stage VC | Drug Discovery | Generating Revenue |
Forbion Exits (91)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Oxular | 02-Jan-2025 | Merger/Acquisition | |
| NewAmsterdam Pharma Company | 13-Dec-2024 | ||
| NewAmsterdam Pharma Company | 15-Feb-2024 | ||
| Aiolos Bio | 14-Feb-2024 | ||
| Oxitope Pharma | 22-Jan-2024 | ||
| Dyne Therapeutics | 05-Jan-2024 | ||
| Forbion European Acquisition | 01-Nov-2023 | ||
| Inversago Pharma | 08-Sep-2023 | ||
| Versanis Bio | 14-Aug-2023 | Merger/Acquisition | |
| VectivBio | 29-Jun-2023 | Merger/Acquisition |
Forbion Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Forbion Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Forbion Co-Investors (186)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BioGeneration Ventures | 8 |
|
|
||
| Novartis Venture Fund |
|
|
|||
| Atlas Venture |
|
|
|||
| RA Capital Management |
|
|
|||
| Novo Holdings |
|
|
Forbion FAQs
-
What is Forbion?
Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands.
-
When was Forbion founded?
Forbion was founded in 2000.
-
Where is Forbion headquartered?
Forbion is headquartered in Naarden, Netherlands.
-
What is Forbion's total asset value?
Forbion has around in total assets under management.
-
How many investments has Forbion made?
Forbion has made 213 investments.
-
What has Forbion invested in?
Forbion has made numerous investments in companies like Numab, Verdiva Bio, and Orbis Medicines within the Drug Discovery and Healthcare Services industries.
-
What has Forbion invested in recently?
Forbion's latest investment was on 09-Jan-2025 in Numab, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
